ADDvise Group AB (publ), through its subsidiaries, develops and supplies equipment and services to healthcare and research facilities in private and public sectors in Sweden and internationally.
Reasonable growth potential and fair value.
Share Price & News
How has ADDvise Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ADDV B has not had significant price volatility in the past 3 months.
7 Day Return
SE Medical Equipment
1 Year Return
SE Medical Equipment
Return vs Industry: ADDV B exceeded the Swedish Medical Equipment industry which returned 23.1% over the past year.
Return vs Market: ADDV B exceeded the Swedish Market which returned 24.1% over the past year.
Price Volatility Vs. Market
How volatile is ADDvise Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is ADDvise Group undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: ADDV B (SEK0.84) is trading below our estimate of fair value (SEK1.47)
Significantly Below Fair Value: ADDV B is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: ADDV B is unprofitable, so we can't compare its PE Ratio to the Medical Equipment industry average.
PE vs Market: ADDV B is unprofitable, so we can't compare its PE Ratio to the Swedish market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate ADDV B's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: ADDV B is good value based on its PB Ratio (1.3x) compared to the SE Medical Equipment industry average (4.6x).
How is ADDvise Group forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ADDV B is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (-0.4%).
Earnings vs Market: ADDV B is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: ADDV B's is expected to become profitable in the next 3 years.
Revenue vs Market: ADDV B's revenue (8.5% per year) is forecast to grow faster than the Swedish market (4.7% per year).
High Growth Revenue: ADDV B's revenue (8.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ADDV B's Return on Equity is forecast to be low in 3 years time (9.6%).
How has ADDvise Group performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ADDV B is currently unprofitable.
Growing Profit Margin: ADDV B is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: ADDV B is unprofitable, but has reduced losses over the past 5 years at a rate of 21.4% per year.
Accelerating Growth: Unable to compare ADDV B's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ADDV B is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (11.8%).
Return on Equity
High ROE: ADDV B has a negative Return on Equity (-0.52%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
How is ADDvise Group's financial position?
Financial Position Analysis
Short Term Liabilities: ADDV B's short term assets (SEK125.2M) exceed its short term liabilities (SEK114.4M).
Long Term Liabilities: ADDV B's short term assets (SEK125.2M) do not cover its long term liabilities (SEK162.5M).
Debt to Equity History and Analysis
Debt Level: ADDV B's debt to equity ratio (242.6%) is considered high.
Reducing Debt: ADDV B's debt to equity ratio has reduced from 263.3% to 242.6% over the past 5 years.
Inventory Level: ADDV B has a low level of unsold assets or inventory.
Debt Coverage by Assets: ADDV B's debt is not covered by short term assets (assets are 0.6x debt).
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ADDV B has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if ADDV B has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
What is ADDvise Group's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: Unable to evaluate ADDV B's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate ADDV B's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if ADDV B's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ADDV B's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of ADDV B's dividend in 3 years as they are not forecast to pay a notable one for the Swedish market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Rikard Akhtarzand (47yo)
Mr. Richard Akhtarzand, also known as Rikard, serves as the Chief Executive Officer, President and Director of ADDvise Group AB (publ). Mr. Akhtarzand serves as Chief Executive Officer and Director at Kivs ...
CEO Compensation Analysis
Compensation vs Market: Rikard's total compensation ($USD280.97K) is above average for companies of similar size in the Swedish market ($USD205.08K).
Compensation vs Earnings: Rikard's compensation has been consistent with company performance over the past year.
|CEO, President & Director||0yrs||kr2.76m||5.82% SEK4.9m|
|Chief Financial Officer||1.3yrs||no data||no data|
|Chief Operating Officer||3.7yrs||no data||0.12% SEK101.6k|
|Legal Counsel||1.1yrs||no data||no data|
|Senior Vice President||0yrs||no data||no data|
|Chief Auditor||4.8yrs||no data||no data|
|Head of Project Management & Service||0yrs||no data||no data|
|Sales Manager of Laboratory Furniture & Safety Ventilation||5.1yrs||no data||no data|
|Consultant||4.8yrs||no data||no data|
Experienced Management: ADDV B's management team is considered experienced (4.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 70.4%.
ADDvise Group AB (publ)'s company bio, employee growth, exchange listings and data sources
- Name: ADDvise Group AB (publ)
- Ticker: ADDV B
- Exchange: OM
- Founded: 1989
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: kr83.693m
- Shares outstanding: 96.91m
- Website: https://www.addvisegroup.se
Number of Employees
- ADDvise Group AB (publ)
- Grev Turegatan 3
- Floor 4
- Stockholm County
- 114 46
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|ADDV A||OM (OMX Nordic Exchange Stockholm)||Yes||Class A Shares||SE||SEK||Dec 2004|
|ADDV B||OM (OMX Nordic Exchange Stockholm)||Class B Shares||SE||SEK||Sep 2015|
ADDvise Group AB (publ), through its subsidiaries, develops and supplies equipment and services to healthcare and research facilities in private and public sectors in Sweden and internationally. The company’s Lab business unit offers laboratory furnishings, safety ventilation products, climate rooms, clean rooms, and laboratory apparatus. Its Healthcare business unit provides medical devices and consumable materials, including defibrillators and chairs for use in the urology and gynecology areas, as well as surgical tables for medical care. The company was formerly known as ADDvise Lab Solutions AB (publ) and changed its name to ADDvise Group AB (publ) in September 2015. ADDvise Group AB (publ) was founded in 1989 and is headquartered in Stockholm, Sweden.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/02/20 23:01|
|End of Day Share Price||2020/02/20 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.